secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001437749-24-004614
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Windtree Therapeutics interim CFO John Tattory resigns; CEO takes over CFO role
-------------------------------------------------------------------------------

- John A. Tattory resigned as Interim CFO effective Feb 15, 2024, by mutual agreement as part of cost-cutting measures, with no dispute.
- CEO Craig E. Fraser will serve as principal financial officer on an interim basis while retaining President and CEO roles.
- Tattory will continue consulting via LifeSci Associates at an agreed hourly rate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774924004614/0001437749-24-004614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774924004614/wint20240215_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-004614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer